IBDEI1HQ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26442,0)
 ;;=300.7^^152^1686^2
 ;;^UTILITY(U,$J,358.3,26442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26442,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,26442,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,26442,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,26443,0)
 ;;=300.81^^152^1686^3
 ;;^UTILITY(U,$J,358.3,26443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26443,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,26443,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,26443,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,26444,0)
 ;;=307.1^^152^1687^1
 ;;^UTILITY(U,$J,358.3,26444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26444,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,26444,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,26444,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,26445,0)
 ;;=307.51^^152^1687^2
 ;;^UTILITY(U,$J,358.3,26445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26445,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,26445,1,5,0)
 ;;=5^Bulemia Nervosa
 ;;^UTILITY(U,$J,358.3,26445,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,26446,0)
 ;;=307.50^^152^1687^3
 ;;^UTILITY(U,$J,358.3,26446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26446,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,26446,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,26446,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,26447,0)
 ;;=333.99^^152^1688^2
 ;;^UTILITY(U,$J,358.3,26447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26447,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,26447,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,26447,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,26448,0)
 ;;=332.0^^152^1688^3
 ;;^UTILITY(U,$J,358.3,26448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26448,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,26448,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,26448,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,26449,0)
 ;;=333.79^^152^1688^1
 ;;^UTILITY(U,$J,358.3,26449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26449,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,26449,1,5,0)
 ;;=5^Acquired Torsion Dystonia NEC
 ;;^UTILITY(U,$J,358.3,26449,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,26450,0)
 ;;=333.85^^152^1688^4
 ;;^UTILITY(U,$J,358.3,26450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26450,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,26450,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,26450,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,26451,0)
 ;;=V87.39^^152^1689^1
 ;;^UTILITY(U,$J,358.3,26451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26451,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,26451,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,26451,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,26452,0)
 ;;=310.0^^152^1690^1
 ;;^UTILITY(U,$J,358.3,26452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26452,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,26452,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,26452,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,26453,0)
 ;;=310.1^^152^1690^3
 ;;^UTILITY(U,$J,358.3,26453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26453,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,26453,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,26453,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,26454,0)
 ;;=310.2^^152^1690^4
 ;;^UTILITY(U,$J,358.3,26454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26454,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,26454,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,26454,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,26455,0)
 ;;=310.81^^152^1690^5
 ;;^UTILITY(U,$J,358.3,26455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26455,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,26455,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;
 ;;$END ROU IBDEI1HQ
